Allianz Global Investors
Our Managers Commentary News & Media
Mutual Funds
Related Products
> Closed-End Funds
> 529 Plan

ALLIANZ FUNDS PROFILE 
All data as of 10.31.09, unless otherwise indicated. 
Allianz NFJ Renaissance Fund
E-mail Print
About this Fund Performance Portfolio Review & Outlook Literature
Allianz NFJ Renaissance Review
09/30/2009
Market Review

The Fund registered double-digit returns for the quarter, underperforming its benchmark the Russell Midcap Value Index. All sectors finished higher for the quarter, extending the upturn that began in early spring as signs of an economic recovery remained mixed. On an absolute basis, holdings in the financials and industrials sectors contributed most to gains for the period. Stock selection decisions in the consumer discretionary, financials, industrials and energy sectors detracted from the Fund’s performance relative to the benchmark. Stock selection decisions in health care and technology benefited returns versus the benchmark.

 

Capital Markets

U.S. equity markets advanced solidly in the third quarter, adding to gains for the year and recovering more of the value lost in the 16-month bear market that ended in March. Although economic growth remained subdued, investors showed newfound enthusiasm for riskier assets, bidding up stock prices especially in the beaten-down financials and materials sectors. During the quarter, value and growth indexes spanning all capitalization segments recorded double-digit returns with value stocks somewhat more in favor. Among value indexes, all sectors registered positive returns with stocks in the financials and industrials sectors contributing most significantly to gains. Utilities and telecommunications stocks posted positive returns but underperformed value indexes.

Performance Commentary

Within the consumer discretionary sector, shares of McGraw-Hill fell as the company reported lower second-quarter profit, partly hurt by a restructuring charge related to job cuts. The company publishes textbooks and owns BusinessWeek magazine and Standard & Poor’s. Its profits report beat Wall Street expectations. But a ruling that Standard & Poor’s must face fraud charges over certain security ratings pressured the company’s share price and the publisher lowered the high end of its full-year adjusted profit guidance. The Fund’s position in H&R Block delivered positive returns for the period but underperformed broadcasters, publishers and other media companies that rebounded from multiple quarters of declines. The tax preparation company reported a quarterly loss in the period but affirmed forecasts for profits for the year.

 

Signs of a nascent economic recovery and an upturn in demand served to boost share prices for companies in the industrials sector, which had been extremely hard hit by recession. The Fund’s position in refuse hauler Waste Management contributed to gains for the period but underperformed some of the sector’s leaders in commercial printing, defense contracting and transportation. The Fund’s position in Fluor Corp declined as the engineering firm experienced a slowdown in U.S. construction projects. Fluor builds large, complex industrial and infrastructure projects. Despite some volatility it has remained profitable throughout the recession and reported positive quarterly earnings during the period.

 

In health care, shares of McKesson Corporation rose as the supplier of information and care management products and services company reported better-than-expected quarterly profits. The pharmaceuticals wholesaler noted that strong cash flow and cost management enabled it to raise its full-year earnings forecast, which helped send share prices higher. Shares of Shire Pharmaceuticals also advanced on a positive quarterly earnings report. The company is in talks with the Food and Drug Administration about bringing a drug for a rare disease to U.S. patients, as rival Genzyme Corp. faces shortages for its best-selling treatments. The Shire drugs are alternatives to treatments made by Genzyme, which is having trouble supplying the drugs since its Boston manufacturing plant was shut down in June following a viral contamination.

 

Gains in the Fund’s technology holdings reflected improved consumer confidence. Communications and information technology company Harris Corp. reported earnings results that topped Wall Street expectations and the company offered a strong forecast, sending the stock up for the period. The company cited new contract wins, improved order rates, and a solid pipeline of new opportunities. CA Inc also posted earnings results that beat Wall Street's expectations and the business-software maker raised its fiscal-year forecast.

Outlook
We expect equity returns to moderate in coming quarters as the effects of cost-cutting initiatives by U.S. corporations run their course and the challenges presented by subdued economic growth and growing unemployment limit further improvements in company fundamentals. We expect that this emerging environment of flat-to-modest market returns will favor managers with demonstrable stock selection skills and companies with durable franchises, solid balance sheets and a commitment to paying dividends. We continue to fully invest our Funds in stocks exhibiting these characteristics along with the potential for stable future cash flows.

Investors should consider the investment objectives, risks, charges and expenses of this Fund carefully before investing. This and other information is contained in the Fund´s prospectus and summary prospectus, if available, which may be obtained by contacting your financial advisor, or by calling 888-877-4626. Click here for the Fund´s prospectus or summary prospectus. Please read them carefully before you invest or send money.

As of June 8, 2009, the Fund's name was changed and the Fund's former subadviser Oppenheimer Capital LLC was replaced with NFJ Investment Group LLC.

 

Past performance is no guarantee of future results. Current and future portfolio holdings are subject to risk. The material contains the current opinions of the author, which are subject to change without notice. Statements concerning financial market trends are based on current market conditions, which will fluctuate. References to specific securities and issuers are for illustrative purposes only and are not intended to be, and should not be interpreted as, recommendations to purchase or sell such securities.

 

There is no guarantee that dividend-paying stocks will continue to pay dividends.

 

When investing in value securities, the market may not have the same value assessment as the manager, and, therefore, the performance of the securities may decline. The Fund normally invests in smaller companies, which may entail greater risk than larger companies, including higher volatility. The Fund may invest in non-U.S. securities, which may entail greater risk due to foreign economic and political developments. The Fund may use derivative instruments for hedging purposes or as part of its investment strategy. Use of these instruments may involve certain costs and risks such as liquidity risk, interest rate risk, market risk, credit risk, management risk and the risk that a fund could not close out a position when it would be most advantageous to do so. Portfolios investing in derivatives could lose more than the principal amount invested in those instruments.

 

The Russell Midcap Value Index measures the performance of those Russell Midcap companies with lower price-to-book ratios and lower forecasted growth values. The stocks are also members of the Russell 1000 Value Index. Unless otherwise noted, index returns reflect the reinvestment of income dividends and capital gains, if any, but do not reflect fees, brokerage commissions or other expenses of investing. It is not possible to invest directly in an index.

 

The Allianz Funds are distributed by Allianz Global Investors Distributors LLC, 1345 Avenue of the Americas, New York, NY 10105-4800, www.allianzinvestors.com, 1-888-877-4626.

 

Investment Products: NOT FDIC INSURED | MAY LOSE VALUE | NOT BANK GUARANTEED

 

Click here to view the Fund's top ten holdings and current sector weightings. All holdings are subject to change.

 

Click here to view the Fund's current month-end performance.


Advisor Login